HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Gemcitabine Hydrochloride

HCID 60749
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
122111-03-9
Standard SMILES
Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
InChIKey
OKKDEIYWILRZIA-OSZBKLCCSA-N
Molecular formula
C9H12ClF2N3O4
Average molar mass
299.66 g/mol
Monoisotopic mass
299.0484399

Overview

Gemcitabine Hydrochloride is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.

Names & identifiers

Preferred name
Gemcitabine Hydrochloride
IUPAC
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
English name
Gemcitabine hydrochloride
Molecular formula
C9H11F2N3O4.ClH
Molecular weight
299.66

Names & synonyms

GEMCITABINE HYDROCHLORIDE122111-03-9Gemcitabine HClLY188011 hydrochlorideGemcitabine HCI2'-Deoxy-2',2'-difluorocytidine monohydrochlorideINFUGEM2'-deoxy-2',2'-difluorocytidine hydrochlorideGemcitabine (as hydrochloride)Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochlorideDTXSID30478492',2'-Difluorodeoxycytidine monohydrochloride
Show more names
gemzarGecitabine2',2'-DIFLUORO-2'-DEOXYCYTIDINE4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochlorideDFDCDDFCDFDCYDGeMsarT11YSY
U347PV74ILLY-188011 HYDROCHLORIDEDTXCID3027827NSC613327FF 10832CHEBI:31647RefChem:57768FF10832

Database identifiers

Properties

Computed structural properties

Topological polar surface area
108 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
6
Rotatable bonds
2
Heavy atoms
19
Formal charge
0
Complexity
426

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
250 °C · >250°C dec.
alpha
48 °; · D +48°; 365 +257.9° (c = 1.0 in deuterated water)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: ≥10mg/mL
form
White powder
pka
3.58 · 3.58 (acidic)
color
White
Water Solubility
25 mg/mL · water: 25mg/mL
λmax
268 nm · 268nm(H2O)(lit.)
Merck
14 · 14,4386
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month.
InChI
InChI=1/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/s3

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (11.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P317, P318, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 62 reports by companies from 17 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (11.3%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Gemcitabine hydrochloride

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Safety data

wgk
3
rtecs
HA3840000
hs_code
29420000
risk_code
21-36/38-46-62-63
Signal word
Danger
Symbol(GHS)
GHS08
hazard_code
Xn,Xi
safety_code
25-26-36/37-53
Storage Class
6.1C - Combustible, acute toxic Cat.3toxic compounds or compounds which causing chronic effects

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

GEMCITABINE HYDROCHLORIDE

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

MeSH Pharmacological ClassificationAntimetabolites that are useful in cancer chemotherapy.
Applications · 3 items

UsesSuitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

DescriptionGemcitabine is a novel nucleoside analog that was launched in 1995 in the Netherlands for the treatment of non-small cell lung cancer (nsclc) and in Sweden for pancreatic cancer. Gemcitabine is a prodrug which is phosphorylated intracellularly by deoxycytadine kinase to its active forms, the di- and triphosphates which bind to DNA competitively. This insertion inhibits processes required for DNA synthesis and metabolism, the essential function for both cell replication and repair. Furthermore, gemcitabine displays an extraordinary array of self-potentiating mechanisms that increase the concentration and prolong the retention of its active nucleotides in tumor cells. The title compound has shown activity against a wide spectrum of human solid tumors including colon, mammary, breast, bladder cancers. Synergistic activity of gemcitabine with other anticancer agents such as cisplatin has been reported.

UsesAn antineoplastic.

Upstream & downstream products

Downstream products

4-Amino-1-(2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone Hydrochloride

Related reactions

18 records
New reaction record
HRID 217106 reaction equation
HRID 217106As product
HRID 217107 reaction equation
HRID 217107As product
HRID 241530 reaction equation
HRID 241530As reactant
HRID 241531 reaction equation
HRID 241531As reactant
HRID 241533 reaction equation
HRID 241533As reactant
HRID 493017 reaction equation
HRID 493017As reactant
HRID 982161 reaction equation
HRID 982161As reactant
HRID 982162 reaction equation
HRID 982162As reactant
PreviousPage 1 of 3

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CAS
122111-03-9
PubChem CID
60749
DTXSID
DTXSID3047849
ChEMBL
CHEMBL1637
UNII
U347PV74IL
EC Number
601-823-3
InChIKey
OKKDEIYWILRZIA-LJAFHONQNA-N
SMILES
[C@H]1(O[C@@H]([C@@H](O)C1(F)F)CO)N1C=CC(N)=NC1=O.Cl |&1:0,2,3,r|
CAS DataBase Reference
122111 · 122111-03-9(CAS DataBase Reference)
EWG's Food Scores
1 · 1
NCI Dictionary of Cancer Terms
gemcitabine hydrochloride; Gemzar
FDA UNII
347 PV74IL · U347PV74IL
NCI Drug Dictionary
gemcitabine hydrochloride
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
360 · H360
Precautionary statements
201 · P201-P202-P280-P308+P313-P405-P501
Hazard Codes
Xn,Xi
Risk Statements
21 · 21-36/38-46-62-63
Safety Statements
25 · 25-26-36/37-53
WGK Germany
3 · 3
RTECS
3840000 · HA3840000
HS Code
29420000 · 29420000
Storage Class
6.1 C · 6.1C - Combustible, acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
1 B · Repr. 1B
Hazard statements
H360
Hazard Classifications
Repr. 1B
Precautionary statements
P201-P202-P280-P308+P313-P405-P501
Acelarin
2',2'-Difluoro-2'-deoxyuridine
Additional notes · 1 item

DefinitionChEBI: A 2'-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic ca cer, bladder cancer and breast cancer.